Skip to content
Disclosery

Trustees of Columbia University in the City of New York

Follow

13F filer, CIK 1420995, NEW YORK, NY

Trustees of Columbia University in the City of New York reported $655,280,284 across 8 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000904454-25-000601

Period
2025-09-30
Reported value
$655M
Holdings
8
Top 10 weight
100%
New
2
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RAPTnew+9,172$237K
VORnew+4,595$224K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SPYreduced-132,017-$87.9M
VIGIL NEUROSCIENCE INCexited-192,973-$1.53M
HEI-Aexited-3,187-$825K
VOR BIOPHARMA INCexited-91,910-$149K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0000904454-25-000601, largest first. % of portfolio is the value over $655,280,284, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SPYSTATE STR SPDR S&P 500 ETF TQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,071,799 shares; 2025Q1: 1,109,343 shares; 2025Q2: 1,112,613 shares; 2025Q3: 980,596 shares 980,596$653M99.69%-132,017Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 47,930 shares; 2025Q1: 47,930 shares; 2025Q2: 47,930 shares; 2025Q3: 47,930 shares 47,930$618K0.09%0Timeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 291,828 shares; 2025Q1: 291,828 shares; 2025Q2: 291,828 shares; 2025Q3: 291,828 shares 291,828$473K0.07%0Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 133,903 shares; 2025Q1: 133,903 shares; 2025Q2: 133,903 shares; 2025Q3: 133,903 shares 133,903$265K0.04%0Timeline
RAPTRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 9,172 shares 9,172$237K0.04%newTimeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,595 shares 4,595$224K0.03%newTimeline
XLOXilio Therapeutics Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 249,635 shares; 2025Q1: 249,635 shares; 2025Q2: 249,635 shares; 2025Q3: 249,635 shares 249,635$210K0.03%0Timeline
SRZNWSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 33,333 shares; 2025Q1: 33,333 shares; 2025Q2: 33,333 shares; 2025Q3: 33,333 shares 33,333$517<0.01%0Timeline

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VIGIL NEUROSCIENCE INCVIGIL NEUROSCIENCE INC192,973$1.53Mshares
HEI-AHEICO CORP NEW3,187$825Kshares
VOR BIOPHARMA INCVOR BIOPHARMA INC91,910$149Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000904454-25-000601 base2025-11-14acceptance time not in the bulk data set